TMDX 13F Hedge Fund and Asset Management Owners

Data as of 2021-01-16
Market Cap	509.537 Million	Shares Outstanding	27.161 Million	Avg 30-day Volume	93.947 Thousand
P/E Ratio	-15.2	Dividend Yield		EPS	-1.28
Price/Sales	28.289	Price cash flow ratio		Price free cash flow ratio	-22.4
Book Value	4.03	Price to Tangible Book	4.82	Alpha	-0.03
Short Interest Ratio		% Short Interest to Float		R-squared	0.360365
BETA	2.16436	52-week High/Low	20.99 / 10.1	Stddev	0.218342

Q3 2020	All 13F Filers	Prior	Change	Hedge Funds ¹	Prior	Change
In top 10:	0	1	-100.0%	0 (0.0%)	1 (0.06%)	-100.0%
Funds Holding:	71	69	2.9%	16 (1.05%)	19 (1.23%)	-15.79%
13F shares:	20.816 Million	20.159 Million	3.26%	6.95 Million	7.475 Million	-7.02%
% Ownership	76.6559	74.3568	3.09%	25.5929	27.5706	-7.17%
New Positions:	14	20	-30.0%	5	8	-37.5%
Increased Positions	32	32	0.0%	5	7	-28.57%
Closed Positions	11	5	120.0%	8	2	300.0%
Reduced Positions	15	11	36.36%	3	1	200.0%
Total Calls	15	0
Total Puts	75 Thousand	0		75 Thousand
PUT/CALL Ratio	5,000.0
¹ hedge funds and active managers as identified by whalewisdom.com through public filings.

Funds Holding TMDX (via 13F filings)

Quarter to view: Refresh Download CSV Download Excel (.xlsx) Download TSV

Market Value:

Ranking:

% of portfolio

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TMDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

14 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

132 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name	Type	Last Reported Shares Held	Last Reported Date	Filings in past year
HASSANEIN WALEED H PRESIDENT & CEO	Officer Director	338,843	2021-01-05	3
RAINES MERILEE	Director	0	2021-01-01	2
GORDON STEPHEN CHIEF FINANCIAL OFFICER	Officer	18,126	2020-12-31	4
SULLIVAN JOHN F VP OF QUALITY & ENGINEERING	Officer	10,828	2020-12-21	3
PROVOST MIRIAM VP OF US REGULATORY & FDA REL.	Officer	4,600	2020-12-11	2
CAREY JOHN F VP OF OPERATIONS	Officer	3,200	2020-09-01	9
TOBIN JAMES R	Director	0	2020-06-04	1
GUNDERSON THOMAS JAMES	Director	0	2020-06-04	1
WEILL DAVID	Director	0	2020-06-04	1
BASILE EDWARD M	Director	0	2020-06-04	1
KHAYAL TAMER I CHIEF COMMERCIAL OFFICER	Officer	0	2020-02-27	2
DAMME LAURA VP, CLINICAL AFFAIRS	Officer	0	2020-02-27	1
KANIA EDWIN M JR	Director	1,019,748	2019-12-12	0
UNITED THERAPEUTICS CORP LUNG BIOTECHNOLOGY PBC	10% Owner	2,053,240	2019-12-09	0
FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC FLAGSHIP VENTURES FUND IV, L.P. FLAGSHIP VENTURES 2007 GENERAL PARTNER LLC FLAGSHIP VENTURES FUND 2007, L.P. AFEYAN NOUBAR	10% Owner	120,595	2019-10-29	0
ABRAMS CAPITAL MANAGEMENT, L.P. ABRAMS CAPITAL MANAGEMENT, LLC ABRAMS CAPITAL, LLC ABRAMS DAVID C ABRAMS CAPITAL PARTNERS II, L.P. RIVA CAPITAL PARTNERS III, L.P. RIVA CAPITAL MANAGEMENT III, LLC	10% Owner	3,499,859	2019-05-06	0
GILBERT JAMES	Director	0	2019-05-01	0

Insider Transactions Last 60 Days

Reporting Owners	Filing Date	Trans Date	Trans Code	Shares	Share Price	Acquired Disposed	Shares Owned after	D/I	10b5	Perf 1d*	Perf 5d*	Max Gain	Max Gain Days	Max Loss	Max Loss Days
HASSANEIN WALEED H - Director - Officer PRESIDENT & CEO	2021-01-14 18:56:13 -0500	2021-01-05	M	123,414	$0.39	a	338,843	direct
HASSANEIN WALEED H - Director - Officer PRESIDENT & CEO	2021-01-14 18:56:13 -0500	2021-01-05	M	123,414		d	0	direct
GORDON STEPHEN - Officer CHIEF FINANCIAL OFFICER	2021-01-05 18:04:42 -0500	2021-01-04	S	1,184	$20.00	d	8,371	direct	yes	-2.0419	-0.7726	3.532	3	-2.0419	2
RAINES MERILEE - Director	2021-01-05 17:57:41 -0500	2021-01-01	A	18,000		a	18,000	direct
GORDON STEPHEN - Officer CHIEF FINANCIAL OFFICER	2021-01-05 18:04:42 -0500	2020-12-31	S	8,816	$20.00	d	9,755	direct	yes	-2.0419	-0.7726	3.532	3	-2.0419	2
SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING	2020-12-22 16:19:19 -0500	2020-12-21	S	1,000	$17.99	d	10,828	direct	yes	-0.3715	5.6263	5.6263	6	-0.3715	2
SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING	2020-12-17 17:57:14 -0500	2020-12-16	M	1,000	$0.39	a	11,828	direct		-1.9818	1.714	1.714	6	-1.9818	2
SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING	2020-12-17 17:57:14 -0500	2020-12-16	M	1,000		a	10,617	direct
SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING	2020-12-17 17:57:14 -0500	2020-12-15	M	3,000		a	11,617	direct	yes
SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING	2020-12-17 17:57:14 -0500	2020-12-15	M	3,000	$0.39	a	13,828	direct	yes	-1.9818	1.714	1.714	6	-1.9818	2
SULLIVAN JOHN F - Officer VP OF QUALITY & ENGINEERING	2020-12-17 17:57:14 -0500	2020-12-15	S	3,000	$16.63	d	10,828	direct	yes	-1.9818	1.714	1.714	6	-1.9818	2
PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.	2020-12-14 16:53:15 -0500	2020-12-11	M	4,600	$3.22	a	4,600	direct		-0.1676	4.7486	4.7486	6	-0.1676	2
PROVOST MIRIAM - Officer VP OF US REGULATORY & FDA REL.	2020-12-14 16:53:15 -0500	2020-12-11	M	4,600		d	23,971	direct

* -

Transaction Code Definitions
Code	Definition
A	Grant, award or other acquisition pursuant to Rule 16b-3(d)
C	Conversion of derivative security
D	Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E	Expiration of short derivative position
F	Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G	Bona fide gift
H	Expiration (or cancellation) of long derivative position with value received
I	Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J	Other acquisition or disposition
L	Small acquisition under Rule 16a-6
M	Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O	Exercise of out-of-the-money derivative security
P	Open market or private purchase of non-derivative or derivative security
S	Open market or private sale of non-derivative or derivative security
U	Disposition pursuant to a tender of shares in a change of control transaction
W	Acquisition or disposition by will or the laws of descent and distribution
X	Exercise of in-the-money or at-the-money derivative security
Z	Deposit into or withdrawal from voting trust

Transmedics Group Inc Chart by YCharts
Yahoo! Finance	finviz
SEC Web Site	SEC DEF 14A Filings

Transmedics Group Inc (TMDX)

WhaleWisdom Alpha

Our Other Reporting & Analysis